ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

CPIX Cumberland Pharmaceutical Inc

1,68
-0,015 (-0,88%)
Zuletzt aktualisiert: 15:45:01
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Cumberland Pharmaceutical Inc CPIX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,015 -0,88% 1,68 15:45:01
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,68 1,68 1,68 1,695
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.4.202422:05PRNUSNEW REPORT SUPPORTS USE OF CALDOLOR® AS A STANDARD OF CARE..
05.3.202423:10EDGAR2Form 8-K - Current report
05.3.202422:05PRNUSCumberland Pharmaceuticals Reports Annual 2023 Financial..
27.2.202422:05PRNUSCUMBERLAND PHARMACEUTICALS TO ANNOUNCE ANNUAL 2023 FINANCIAL..
09.2.202423:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28.12.202323:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.12.202323:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.12.202323:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.12.202306:15EDGAR2Form EFFECT - Notice of Effectiveness
15.12.202322:14EDGAR2Form DEL AM - Delaying amendment
14.12.202323:09EDGAR2Form S-3 - Registration statement under Securities Act of..
06.12.202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.12.202323:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.11.202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.11.202323:21EDGAR2Form 8-K - Current report
07.11.202322:05PRNUSCumberland Pharmaceuticals Reports Third Quarter 2023..
03.11.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.11.202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.10.202321:05PRNUSCUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2023..
17.10.202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.10.202315:11EDGAR2Form 8-K - Current report
10.10.202322:05PRNUSNEW VIBATV® PEDIATRIC PUBLICATION HIGHLIGHTS ITS SAFETY IN..
03.10.202323:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.9.202316:55DJNCorrection to SEC Fines Article
27.9.202316:43DJNSEC Fines 5 Public Companies, Insiders Over Reporting..
19.9.202315:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.9.202323:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.8.202323:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.8.202323:23EDGAR2Form 8-K - Current report
08.8.202322:05PRNUSCumberland Pharmaceuticals Reports Revenue and Earnings..
01.8.202322:05PRNUSCUMBERLAND PHARMACEUTICALS TO ANNOUNCE SECOND QUARTER 2023..
30.6.202323:20EDGAR2Form 8-K - Current report
26.6.202315:00PRNUSNEW PUBLICATION SUPPORTS THE USE OF CALDOLOR® IN NEWBORN..
23.5.202315:00PRNUSCUMBERLAND PHARMACEUTICALS ANNOUNCES FDA CLEARANCE OF IND..
15.5.202315:00PRNUSCALDOLOR® NOW FDA APPROVED FOR TREATMENT OF FEVER & PAIN IN..
09.5.202322:05PRNUSCumberland Pharmaceuticals Reports First Quarter 2023..
02.5.202322:05PRNUSCUMBERLAND PHARMACEUTICALS TO ANNOUNCE FIRST QUARTER 2023..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock